SCOPUS 정보 검색 플랫폼

Volumn 48, Issue 2, 2001, Pages 134-141

Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients

(7) Reif, Stefanie b Kingreen, Dorothea b Kloft, Charlotte b Grimm, Jenny b Siegert, Wolfgang b Schunack, Walter b Jaehde, Ulrich b

a FREIE UNIVERSITÄT BERLIN (Germany)

b UNIVERSITY OF BONN (Germany)

Author keywords

Bioequivalence; Etoposide; Etoposide phosphate; High dose chemotherapy; Pharmacokinetics

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; DOXORUBICIN; ETOPOFOS; ETOPOSIDE; IFOSFAMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MEGADOSE; HUMAN; LYMPHOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CROSS-OVER STUDIES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; ETOPOSIDE; HUMANS; IFOSFAMIDE; INFUSIONS, INTRAVENOUS; LYMPHOMA; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; PRODRUGS; THERAPEUTIC EQUIVALENCY;

EID: 0034896006 PISSN: 03445704 EISSN: None Source Type: Journal
DOI: 10.1007/s002800100280 Document Type: Article

Times cited : (16)

References (34)

1
- 0023201962
- Total body irradiation and high-dose etoposide: A new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies
- published erratum appears in Blood 1987 69(6):1789
- (1987) Blood , vol.69 , pp. 1015
- Blume, K.G.¹ Forman, S.J.² O'Donnell, M.R.³ Doroshow, J.H.⁴ Krance, R.A.⁵ Nademanee, A.P.⁶ Snyder, D.S.⁷ Schmidt, G.M.⁸ Fahey, J.L.⁹ Metter, G.E.¹⁰ Hill, L.R.¹¹ Findley, D.O.¹² Sniecinski, I.J.¹³

2
- 0028786202
- Phase I and pharmacokinetic study of etoposide phosphate
- (1995) Anticancer Drugs , vol.6 , pp. 637
- Brooks, D.J.¹ Srinivas, N.R.² Alberts, D.S.³ Thomas, T.⁴ Igwemezie, L.N.⁵ McKinney, L.M.⁶ Randolph, J.⁷ Schacter, L.⁸ Kaul, S.⁹ Barbhaiya, R.H.¹⁰

3
- 0028020863
- Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors
- (1994) J Clin Oncol , vol.12 , pp. 1902
- Budman, D.R.¹ Igwemezie, L.N.² Kaul, S.³ Behr, J.⁴ Lichtman, S.⁵ Schulman, P.⁶ Vinciguerra, V.⁷ Allen, S.L.⁸ Kolitz, J.⁹ Hock, K.¹⁰ O'Neill, K.¹¹ Schacter, L.¹² Barbhaiya, R.H.¹³

4
- 0004324584
- Food and Drug Administration, Rockville
- (1992) Statistical procedures for bioequivalence studies using a standard two-treatment crossover design

5
- 0004427562
- Food and Drug Administration, Rockville
- (1999) BA and BE studies for orally administered drugs (draft guidance)

6
- 0027529872
- Busulfan/etoposide - Initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia
- (1993) Blood , vol.81 , pp. 319
- Chao, N.J.¹ Stein, A.S.² Long, G.D.³ Negrin, R.S.⁴ Amylon, M.D.⁵ Wong, R.M.⁶ Forman, S.J.⁷ Blume, K.G.⁸

7
- 0028897601
- A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma
- (1995) Cancer , vol.75 , pp. 1354
- Chao, N.J.¹ Kastrissios, H.² Long, G.D.³ Negrin, R.S.⁴ Horning, S.J.⁵ Wong, R.M.⁶ Blaschke, T.F.⁷ Blume, K.G.⁸

8
- 0003478656
- European Agency for the Evaluation of Medicinal Products, London
- (1998) Note for guidance on the investigation of bioavailability and bioequivalence (draft)

9
- 0025894815
- Unaltered pharmacokinetics after the administration of high-dose etoposide without prior dilution
- (1991) Cancer Chemother Pharmacol , vol.28 , pp. 214
- Ehninger, G.¹ Proksch, B.² Schmidt, H.³ Waidelich, P.⁴ Eichel, B.⁵ Dopfer, R.⁶

10
- 0019428941
- High-performance liquid chromatography determination of 4′-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene-beta-D- glucopyranoside) (VP 16-213) in human plasma
- (1981) J Chromatogr , vol.222 , pp. 141
- Farina, P.¹ Marzillo, G.² D'Incalci, M.³

11
- 0028908141
- Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5
- (1995) Clin Cancer Res , vol.1 , pp. 105
- Fields, S.Z.¹ Igwemezie, L.N.² Kaul, S.³ Schacter, L.P.⁴ Schilder, R.J.⁵ Litam, P.P.⁶ Himpler, B.S.⁷ McAleer, C.⁸ Wright, J.⁹ Barbhaiya, R.H.¹⁰ Langer, C.J.¹¹ O'Dwyer, P.¹²

12
- 0018077177
- IGPHARM: Interactive graphic package for pharmacokinetic analysis
- (1978) Comp Biomed Res , vol.11 , pp. 345
- Gomeni, C.¹ Gomeni, R.²

13
- 0025265751
- Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer
- (1990) Drugs , vol.39 , pp. 438
- Henwood, J.M.¹ Brogden, R.N.²

14
- 0029921747
- Hypersensitivity reactions to etoposide
- (1996) Ann Pharmacother , vol.30 , pp. 367
- Hoetelmans, R.M.¹ Schornagel, J.H.² Ten Bokkel Huinink, W.W.³ Beijnen, J.H.⁴

15
- 0029780802
- The clinical pharmacology of etoposide: An update
- (1996) Cancer Treat Rev , vol.22 , pp. 179
- Joel, S.¹

16
- 0028030326
- Etoposide dosage and pharmacodynamics
- (1994) Cancer Chemother Pharmacol , vol.34 , pp. S69
- Joel, S.P.¹ Shah, R.² Slevin, M.L.³

17
- 0028871358
- Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid tumors
- (1995) J Clin Oncol , vol.13 , pp. 2835
- Kaul, S.¹ Igwemezie, L.N.² Stewart, D.J.³ Fields, S.Z.⁴ Kosty, M.⁵ Levithan, N.⁶ Bukowski, R.⁷ Gandara, D.⁸ Goss, G.⁹ O'Dwyer, P.¹⁰ Schacter, L.P.¹¹ Barbhaiya, R.H.¹²

18
- 0029947578
- Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumors
- (1996) Cancer Chemother Pharmacol , vol.38 , pp. 378
- Kreis, W.¹ Budman, D.R.² Vinciguerra, V.³ Hock, K.⁴ Baer, J.⁵ Ingram, R.⁶ Schacter, L.P.⁷ Fields, S.Z.⁸

19
- 0028302760
- Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: A phase I study with apparent activity in non-small-cell lung cancer
- (1994) J Clin Oncol , vol.12 , pp. 1251
- Krigel, R.L.¹ Palackdharry, C.S.² Padavic, K.³ Haas, N.⁴ Kilpatrick, D.⁵ Langer, C.⁶ Comis, R.⁷

20
- 0028341015
- Pharmacokinetics of undiluted or diluted high-dose etoposide with or without busulfan administered to patients with hematologic malignancies
- (1994) J Clin Oncol , vol.12 , pp. 1468
- Mross, K.¹ Bewermeier, P.² Kruger, W.³ Stockschlader, M.⁴ Zander, A.⁵ Hossfeld, D.K.⁶

21
- 0030499603
- Bioequivalence assessment of etoposide phosphate and etoposide using pharmacodynamic and traditional pharmacokinetic parameters
- (1996) J Pharmacokinet Biopharm , vol.24 , pp. 313
- Mummaneni, V.¹ Kaul, S.² Igwemezie, L.N.³ Newell, D.R.⁴ Porter, D.⁵ Thomas, H.⁶ Calvert, A.H.⁷ Winograd, B.⁸ Barbhaiya, R.H.⁹

22
- 6844250116
- Population pharmacokinetics of total and unbound etoposide
- (1998) Cancer Chemother Pharmacol , vol.41 , pp. 125
- Nguyen, L.¹ Chatelut, E.² Chevreau, C.³ Tranchand, B.⁴ Lochon, I.⁵ Bachaud, J.M.⁶ Pujol, A.⁷ Houin, G.⁸ Bugat, R.⁹ Canal, P.¹⁰

23
- 0001008029
- An efficient method to finding the minimum of a function of several variables without calculating derivatives
- (1964) Comput J , vol.7 , pp. 155
- Powell, M.J.D.¹

24
- 0024041278
- Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate
- (1988) Proc Natl Acad Sci U S A , vol.85 , pp. 4842
- Senter, P.D.¹ Saulnier, M.G.² Schreiber, G.J.³ Hirschberg, D.L.⁴ Brown, J.P.⁵ Hellstrom, I.⁶ Hellstrom, K.E.⁷

25
- 0028229053
- High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: A phase I/II study
- The German Testicular Cancer Cooperative Study Group
- (1994) J Clin Oncol , vol.12 , pp. 1223
- Siegert, W.¹ Beyer, J.² Strohscheer, I.³ Baurmann, H.⁴ Oettle, H.⁵ Zingsem, J.⁶ Zimmermann, R.⁷ Bokemeyer, C.⁸ Schmoll, H.J.⁹ Huhn, D.¹⁰

26
- 0024570002
- Altered protein binding of etoposide in patients with cancer
- (1989) Clin Pharmacol Ther , vol.45 , pp. 49
- Stewart, C.F.¹ Pieper, J.A.² Arbuck, S.G.³ Evans, W.E.⁴

27
- 0026095978
- Relation of systemic exposure to unbound etoposide and hematologic toxicity
- (1991) Clin Pharmacol Ther , vol.50 , pp. 385
- Stewart, C.F.¹ Arbuck, S.G.² Fleming, R.A.³ Evans, W.E.⁴

28
- 0030854622
- Considerable plasma levels of a cytotoxic etoposide metabolite in patients undergoing high-dose chemotherapy
- (1997) Eur J Cancer , vol.33 , pp. 978
- Stremetzne, S.¹ Jaehde, U.² Kasper, R.³ Beyer, J.⁴ Siegert, W.⁵ Schunack, W.⁶

29
- 0031466176
- Determination of the cytotoxic catechol metabolite of etoposide (3′O-demethyletoposide) in human plasma by high-performance liquid chromatography
- (1997) J Chromatogr B Biomed Sci Appl , vol.703 , pp. 209
- Stremetzne, S.¹ Jaehde, U.² Schunack, W.³

30
- 0021679906
- Influence of surface-active food additives on the integrity and permeability of rat intestinal mucosa
- (1984) Food Chem Toxicol , vol.22 , pp. 861
- Tagesson, C.¹ Edling, C.²

31
- 0029061892
- A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days
- (1995) Clin Pharmacol Ther , vol.57 , pp. 499
- Thompson, D.S.¹ Greco, A.² Miller, A.A.³ Srinivas, N.R.⁴ Igwemezie, L.N.⁵ Hainsworth, J.D.⁶ Schacter, L.P.⁷ Kaul, S.⁸ Barbhaiya, R.H.⁹ Garrow, C.¹⁰ Hande, K.R.¹¹

32
- 0032912157
- Effect of Tween-80 on cell killing by etoposide in human lung adenocarcinoma cells
- (1999) Cancer Chemother Pharmacol , vol.43 , pp. 29
- Tsujino, I.¹ Yamazaki, T.² Masutani, M.³ Sawada, U.⁴ Horie, T.⁵

33
- 0028178551
- Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide
- (1994) Biochem Pharmacol , vol.47 , pp. 1157
- Walker, D.¹ Flinois, J.P.² Monkman, S.C.³ Beloc, C.⁴ Boddy, A.V.⁵ Cholerton, S.⁶ Daly, A.K.⁷ Lind, M.J.⁸ Pearson, A.D.⁹ Beaune, P.H.¹⁰ Idle, J.R.¹¹

34
- 0032422493
- The cause of polyurethane catheter cracking during constant infusion of etoposide (VP-16) injection
- (1998) Yakugaku Zasshi , vol.118 , pp. 581
- Yokoyama, H.¹ Aoyama, T.² Matsuyama, T.³ Yamamura, Y.⁴ Nakajima, K.⁵ Nakamura, K.⁶ Sato, H.⁷ Kotaki, H.⁸ Chiba, S.⁹ Hirai, H.¹⁰ Yazaki, Y.¹¹ Iga, T.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.